Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 27.71%
March 31, 2026 26.52%
December 31, 2025 26.18%
September 30, 2025 26.82%
June 30, 2025 27.72%
March 31, 2025 26.26%
December 31, 2024 24.81%
September 30, 2024 25.62%
June 30, 2024 26.83%
March 31, 2024 26.36%
December 31, 2023 25.13%
September 30, 2023 26.02%
June 30, 2023 26.06%
March 31, 2023 26.23%
December 31, 2022 24.75%
September 30, 2022 29.20%
June 30, 2022 30.54%
March 31, 2022 29.90%
December 31, 2021 31.61%
September 30, 2021 31.83%
June 30, 2021 30.53%
March 31, 2021 36.21%
December 31, 2020 40.40%
September 30, 2020 38.43%
June 30, 2020 25.30%
Date Value
March 31, 2020 23.57%
December 31, 2019 25.61%
September 30, 2019 25.80%
June 30, 2019 26.53%
March 31, 2019 26.25%
December 31, 2018 25.69%
September 30, 2018 25.97%
June 30, 2018 27.09%
March 31, 2018 25.16%
December 31, 2017 27.48%
September 30, 2017 27.83%
June 30, 2017 28.74%
March 31, 2017 27.55%
December 31, 2016 30.44%
September 30, 2016 30.95%
June 30, 2016 32.15%
March 31, 2016 30.95%
December 31, 2015 30.28%
September 30, 2015 31.07%
June 30, 2015 32.08%
March 31, 2015 33.31%
December 31, 2014 35.11%
September 30, 2014 35.63%
June 30, 2014 36.05%
March 31, 2014 34.65%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. 32.53%
DaVita, Inc. 27.98%
CVS Health Corp. 14.85%
OPKO Health, Inc. 37.32%
Psychemedics Corp. --